Pulmonary embolism (PE) in transit in heparin-induced thrombocytopenia (HIT) with negative serotonin-release assay (SRA)

Authors

Tayyab Cheema, Advocate Aurora HealthFollow
Tri Kieu, Internal Medicine, West Suburban Medical Center, Oak Park, USA.
Mark Balek, Cardiology, West Suburban Medical Center, Oak Park, USA.
Muhammad Ahmad, Advocate Aurora HealthFollow
Pooja Singh, Advocate Aurora HealthFollow

Recommended Citation

Cheema T, Kieu T, Balek M, Ahmad M, Singh P. Pulmonary Embolism (PE) in Transit in Heparin-Induced Thrombocytopenia (HIT) With Negative Serotonin-Release Assay (SRA). Cureus. 2022;14(6):e25868. Published 2022 Jun 12. doi:10.7759/cureus.25868

Affiliations

Advocate Illinois Masonic Medical Center

Abstract

Pulmonary embolism (PE) is a potentially lethal condition, although frequently diagnosed, and is rarely associated with transit on initial presentation. Heparin-induced thrombocytopenia (HIT) can cause both arterial thrombus formation and venous thromboembolism. The two forms of HIT must be differentiated in order to guide management. We present a complex and unique case of PE in transit secondary to HIT diagnosed in a patient with a negative serotonin assay.

Document Type

Article

PubMed ID

35698467